PLx Pharma Inc. Common Stock
PLXP
PLXP was delisted on the 12th of April, 2023.
4 hedge funds and large institutions have $161 invested in PLx Pharma Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 31 closing their positions.
88% less funds holding
Funds holding: 34 → 4 (-30)
97% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 31
100% less capital invested
Capital invested by funds: $478K → $161 (-$477K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
|
+$2.63K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$192K |
| 2 |
BlackRock
New York
|
-$54K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$37.6K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$30.9K |
| 5 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
-$27.2K |
PLXP Hedge Fund Activity: Q2 2023 in Review
4 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in PLx Pharma Inc. Common Stock (PLXP) for Q2 2023, worth a combined $161 — down 100% from $478K a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of PLXP and 1 opened new positions — a net loss of 30 holders — while 1 trimmed existing stakes and 0 added.
The largest buyer was Baader Bank Aktiengesellschaft, opening a new position worth an estimated $2.63K. The largest seller was Park West Asset Management, exiting entirely with an estimated $192K sold.
- 4 institutional investors held PLx Pharma Inc. Common Stock (PLXP) as of Q2 2023, down from 34 in Q1 2023.
- Funds reported $161 of PLx Pharma Inc. Common Stock stock for Q2 2023, down 100% quarter-over-quarter.
- 1 fund opened new PLx Pharma Inc. Common Stock positions in Q2 2023 and 31 closed out, a net change of -30 holders.
- The largest PLx Pharma Inc. Common Stock buyer in Q2 2023 was Baader Bank Aktiengesellschaft, an estimated $2.63K added.
- The largest PLx Pharma Inc. Common Stock seller in Q2 2023 was Park West Asset Management, an estimated $192K sold.
Based on aggregated 13F filings for Q2 2023.